Lucid Diagnostics Inc.LUCDEarnings & Financial Report
Nasdaq · Health Care · Surgical & Medical Instruments & Apparatus
Lucid Diagnostics Inc. is a commercial-stage medical diagnostics firm focused on non-invasive screening tests for upper gastrointestinal diseases, including early detection of esophageal cancer and pre-cancerous lesions. It mainly serves healthcare providers and clinical partners across the United States, targeting at-risk patient populations.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| PAVmed | 52.70% | 31.3M | ▼ -12.50pp | 2024-12-12 |
| NOS. OF ABOVE PERSONS | 9.90% | 5.0M | flat | 2024-07-08 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-02-20 | Debra White | Director | Grant | 123.0K | $0.00 | $0 |
| 2026-02-20 | Sparks Ronald M | Director | Grant | 123.0K | $0.00 | $0 |
| 2026-02-20 | Lishan Aklog | Chief Executive Officer | Grant | 2.17M | $0.00 | $0 |
| 2026-02-20 | PALUMBO JOHN R | Director | Grant | 123.0K | $0.00 | $0 |
| 2026-02-20 | Stanley Lapidus | Director | Grant | 123.0K | $0.00 | $0 |
| 2026-02-20 | O'Neil Shaun | President and COO | Grant | 620.0K | $0.00 | $0 |
| 2026-02-20 | Dennis Matheis | Director | Grant | 123.0K | $0.00 | $0 |
| 2026-02-20 | MCGRATH DENNIS M | Chief Financial Officer | Grant | 470.0K | $0.00 | $0 |
| 2026-02-20 | Cox James L | Director | Grant | 123.0K | $0.00 | $0 |
| 2026-02-20 | Gordon Michael Adam | General Counsel and Secretary | Grant | 300.0K | $0.00 | $0 |
1–10 of 11
Page 1 / 2